Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Tanaka

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
Blood|March 5, 2014
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemiaShuichi Mizuta, Keitaro Matsuo, Satoshi Nishiwaki, et al.
Bone Marrow Transplantation|July 31, 2021
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCTYu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, et al.
International Journal of Hematology|May 16, 2022
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysisKihyun Kim, Chang-Ki Min, Youngil Koh, et al.
Cancer Science|September 25, 2020
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
International Journal of Hematology|October 29, 2022
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
International Journal of Cancer|March 24, 2010
p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5Takahiko Kobayashi, Junich Ishida, Manabu Musashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2013
Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantationYusuke Shono, Souichi Shiratori, Mizuha Kosugi-Kanaya, et al.
Experimental Hematology|February 16, 2023
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myelomaRyosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, et al.
International Journal of Hematology|April 6, 2011
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in JapanMinako Iida, Takahiro Fukuda, Kazuhiro Ikegame, et al.
Transplantation and Cellular Therapy|September 30, 2022
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic LeukemiaMasamitsu Yanada, Kensuke Matsuda, Hiroto Ishii, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Blood|March 5, 2014
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemiaShuichi Mizuta, Keitaro Matsuo, Satoshi Nishiwaki, et al.
Bone Marrow Transplantation|July 31, 2021
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCTYu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, et al.
International Journal of Hematology|May 16, 2022
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysisKihyun Kim, Chang-Ki Min, Youngil Koh, et al.
Cancer Science|September 25, 2020
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
International Journal of Hematology|October 29, 2022
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
International Journal of Cancer|March 24, 2010
p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5Takahiko Kobayashi, Junich Ishida, Manabu Musashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2013
Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantationYusuke Shono, Souichi Shiratori, Mizuha Kosugi-Kanaya, et al.
Experimental Hematology|February 16, 2023
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myelomaRyosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, et al.
International Journal of Hematology|April 6, 2011
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in JapanMinako Iida, Takahiro Fukuda, Kazuhiro Ikegame, et al.
Transplantation and Cellular Therapy|September 30, 2022
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic LeukemiaMasamitsu Yanada, Kensuke Matsuda, Hiroto Ishii, et al.
Pageof 27